| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2004;35:2635.)
© 2004 American Heart Association, Inc.
Articles |
From the Magnetic Resonance Research Center, Departments of Diagnostic Radiology and Biomedical Engineering, School of Medicine and Faculty of Engineering, Section of Bioimaging Sciences, Yale University, New Haven, Conn.
Correspondence to Dr Fahmeed Hyder, TAC N143, 300 Cedar St, Yale University, New Haven, CT 06510. E-mail fahmeed.hyder{at}yale.edu
| Abstract |
|---|
|
|
|---|
) is reflected by local energy metabolism (CMRO2) in rat brain. We used extracellular recordings to measure 
/
and calibrated fMRI (ie, using fMRI signal, CBF, and CBV maps) to measure
CMRO2/CMRO2 during sensory stimulation. We found that
CMRO2/CMRO2 is 

/
, which suggests efficient energy use during brain work. Thus, calibrated fMRI provides data on where and by how much the neuronal activity has changed. Possibilities of utilizing calibrated fMRI as a neuroimaging method are discussed.
Key Words: ATP blood flow energy metabolism magnetic resonance spectroscopy neurons oxygen
| Physiology of Neuroimaging |
|---|
|
|
|---|
The brain is composed of a restless collection of cells incessantly working (ie, receiving and distributing signals) to preserve functional integrity. Glucose is the main carbon source for the neuronal and glial cells in the adult mammalian brain, and its oxidation produces most of the ATP needed to sustain normal function.5 Cerebral metabolic rates of oxygen (CMRO2) and glucose (CMRglc) utilization can be linked by the oxygen to glucose index (OGI), which is theoretically 6 for complete oxidation of glucose.
|
|
Since the measured OGI is between 5 and 6 under a wide range of physiological conditions,6 it is generally accepted that glucose oxidation provides energy exclusively for normal cellular work,5,7 in which the OGI is only slightly decreased with increased workload6,7 (Equation 1), eg, for sensory tasks.
Because the brain in the adult human has a very high energetic demand, approximately 10 times that expected simply on the basis of its weight, 8 even transient limitations in oxygen supply can critically harm the function of neuronal and glial cells. Since the oxygen reserve of the mammalian brain is not very significant,5 continuous supply of blood (providing nutrients and removing waste) is necessary for normal function if activities of neurons and glia are to be tightly correlated with their energy use9 (Figure 1). Thus, cerebral blood flow (CBF) or cerebral blood volume (CBV) may provide changes in ongoing neuronal function indirectly.5,8 Since modern-day neuroimaging methods (eg, H215O-PET and H216O-fMRI) measure components of CBF (or CBV), the inherent assumption is that these maps reflect changes in neuronal energy and hence alterations in neuronal activity. The fMRI method falls into this category4 and can be explained by functional hyperemia5 as follows:
|
|
|
which suggests that oxygen molecules permeating across the blood-brain barrier are related to the arteriovenous concentration difference (ie, CaCv) in a quantitative manner. Since arterial blood is fully oxygenated, the arteriovenous difference reflects the deoxyhemoglobin concentration in the capillary bed. In an activated region, the difference between Ca and Cv becomes smaller because Cv increases as a result of functional hyperemia (ie, increased blood oxygenation), which in turn is consistent with a larger fractional increase in CBF than in CMRO2 (Equation 2). Thus, a metabolically driven increase in local perfusion is consistent with a drop in deoxyhemoglobin.
Two prior independent observations10,11 provide insights about Equation 2. Hill10 showed that saturation of hemoglobin with oxygen changed the color of erythrocytes: the fully oxygenated form is bright red, whereas the fully deoxygenated form is nearly black. Penfield11 demonstrated that arterial ends of cerebral capillaries were almost always red, whereas venous ends were purple and veins became redder when the local cellular workload was regionally increased. These observations provide a link between functional hyperemia and changes in local neuronal activity. In an activated region, the arteriovenous difference becomes smaller and can be decreased only if the oxygenation of the capillary bed is increased. This is consistent with a drop in deoxyhemoglobin at the venous end of the capillary bed. Since deoxyhemoglobin is paramagnetic and attenuates the fMRI signal (S),4 a small decrease in venous deoxyhemoglobin therefore enhances S by
S. Therefore, a qualitative understanding of functional hyperemia suggests raised blood oxygenation with increased neuronal activity, and a larger increase in CBF than CMRO2 would be expected for a positive fMRI signal change,4 as shown in the following equation:
|
|
where M and N are measurable physiological and magnetic constants and
CMRO2/CMRO2,
CBF/CBF,
CBV/CBV, and
S/S are changes induced by a task.
| Calibrating fMRI: Energy Metabolism, Blood Perfusion, and Cellular Activity |
|---|
|
|
|---|
CMRO2/CMRO2,
CMRglc/CMRglc, and
CBF/CBF have been controversial for more than a decade because some PET studies14,16 had shown that
CMRO2/CMRO2 was negligible in comparison to
CBF/CBF or
CMRglc/CMRglc. The main proposal from these PET studies14,16 was that the energy-producing pathway of the brain switched from an efficient oxidative mode (during unstimulated conditions) to a less efficient nonoxidative mode (during stimulated conditions).
|
First, with regard to energetic concerns, there is only a minor difference between fractional changes in CMRglc and CMRO2 (Table), which suggests that glucose oxidation is still the abundant source of energy during activation in the awake, nonanesthetized human brain.57 While the small difference between
CMRglc/CMRglc and
CMRO2/CMRO2 gathered from other laboratories (Figure 2) qualitatively supports the suggestion from the PET studies14,16 that
CMRglc/CMRglc is 
CMRO2/CMRO2, glucose oxidation still provides >90% of the ATP during activation at steady state,24,25 and the excess lactate generated may be effluxed into the blood to be used elsewhere.6,25
|
Second, for the physiological basis of fMRI, there is a positive difference between fractional changes in CBF and CMRO2 (Table). The small difference between
CBF/CBF and
CMRO2/CMRO2 gathered from other laboratories (Figure 2) qualitatively supports the suggestion from the PET studies14,16 that
CBF is 
CMRO2/CMRO2. However, the (
CMRO2/CMRO2)/(
CBF/CBF) ratios in humans26 and rats27 are generally similar (
0.7) and are significantly different from the ratio from the PET studies of Fox and Raichle14 and Fox et al16 (
0.1). Thus, most of the CBF-CMRO2 data are not in agreement with predictions from diffusion-limited models of oxygen transport,28,29 which suggest that
CBF/CBF is >>
CMRO2/CMRO2. Rather, models that reveal a more efficient oxygen transport process26,27 are in better agreement with most of the CBF-CMRO2 data.
While cognitive neuroscientists have embraced the indirect fMRI method because of its ease in application, biomedical engineers have been exploring the neuronal basis of fMRI by combining electrophysiological methods. The correlations that have been observed between fMRI and electric signals are based on aspects of spatial localization and/or temporal dynamics.3034 Despite the large disparities in the temporal dynamics as well as spatial responses of each signal type, at best these correlations are delicate because one still cannot quantitatively infer from the conventional fMRI data the degree by which the neuronal activity has changed within an activated focus.
A major effort in our laboratory is to derive the neurophysiological basis of fMRI, which has its roots in biophysics.7,35 We exploited the fact that fMRI has 2 parts (Equation 3): one supports the extensive bioelectric work (described by the CBF-CMRO2 correlation) needed to sustain the excitability of neurons, and the other is the required vasodilation (portrayed by the CBF-CBV correlation), which is the mechanical response involved in removal/delivery of waste/nutrients.9 The fMRI signal was calibrated by MRI and MR spectroscopy (MRS) measurements36,37 of the 2 underlying relationships, which in turn allowed calculation of changes in CMRO2 with the use of S, CBF, and CBV maps (Figure 3).
|
While details of the multimodal MRI methods are discussed elsewhere, 24 the 13C-MRS method for measuring CMRO2 of the abundant excitatory and inhibitory neurotransmitters,25 glutamate and
-aminobutyric acid (GABA), is important to highlight because these measurements validate the calibrated fMRI method. Intravenous infusion of a substrate (eg, glucose, acetate, or ß-hydroxy butyrate) enriched with the nonradioactive, stable 13C isotope results in time-dependent appearance of the 13C label in metabolite pools, thereby allowing flux quantification under steady state conditions.7 Time courses of 13C label flow into pools of glutamate, glutamine, and GABA have been the primary in vivo measurements.7,25 The time course of 13C turnover of glutamate-C4 can be converted into a measure of the neuronal tricarboxylic acid (TCA) cycle flux, and CMRO2 may be determined from this flux because of established stoichiometry between reducing equivalents generated by the TCA cycle and oxidative phosphorylation.7,25
Since energy is defined as the capability of doing work in a nondissipating system,38 we inquired whether brain cells utilize energy by an amount equal to the degree of work done. We used extracellular recordings to measure the spiking frequency of a neuronal ensemble (
) as a reliable and quantifiable measure of brain work.39 Our results showed that
CMRO2/CMRO2 was approximately equal to 
/
. These results suggest that the neuronal energy expended is commensurate with the additional work being done in a localized region; furthermore, the calibrated fMRI method used to obtain CMRO2 maps provides a view of the ensemble work within a voxel.40
| Materials and Methods |
|---|
|
|
|---|
-chloralose (anesthetic agent) and D-tubocurarine chloride (paralyzing agent). The anesthesia was first maintained at a low dose (condition I) followed by a higher dose (condition II) to achieve high and low basal activity levels, respectively, in the same rat.39 The contralateral forelimb was stimulated (2 mA; 0.3 ms; 3 Hz) with 2 copper electrodes.
CMRO2 Measurements
All MRI and MRS data were obtained on a modified 7-T horizontal-bore animal system that has provided high fMRI sensitivity for a variety of rodent models.4144 A multimodal fMRI method45 was used to measure
S/S and
CBF/CBF under fully relaxed conditions in an interleaved manner. An MRI contrast agent was slowly infused after collection of
S/S and
CBF/CBF data in both conditions I and II;
CBV/CBV was measured in condition II, and in condition I
CBV/CBV was estimated from the
CBF/CBF.39 The multimodal data were then used to calculate
CMRO2/CMRO2 in layer 4 of the somatosensory cortex46 for conditions I and II36,37 with the use of Equation 3.
Extracellular Recordings
High-impedance microelectrodes were placed at a depth of layer 4 within the somatosensory cortex in the contralateral and ipsilateral forelimb region.46 High signal-to-noise ratio spikes from the ensemble around the electrode tip were identified by shape recognition.39 The spikes recognized in the first experimental run of condition I were used to process the data collected in all subsequent experimental runs (in the same rat). The data were then converted to reflect the relative spiking frequency (
) of the neuronal ensemble.39
| Changes in Energetics and Redeployment of Neuronal Activity |
|---|
|
|
|---|
for the contralateral side were significant. No significant stimulation-induced changes in CMRO2 and
were observed in the ipsilateral side. The stimulation increased CMRO2 by
40% from the basal activity level I prestimulus condition. The prestimulus condition of basal activity level II was lowered by
32% from the same condition of basal activity level I, whereas the stimulation increased CMRO2 by
102% from the prestimulus condition of basal activity level II. Similar magnitudes of changes in
were observed. In the prestimulus condition of both basal activity levels, stimulation produced approximately the same total magnitude of activity in both CMRO2 and
, while the increments varied accordingly (Figure 4). Dose-dependent decrease of basal activity level CMRglc has been observed under halothane,47
-chloralose,48 and phenobarbital49 anesthesia. Similarly, stimulation-induced increments in neuronal activity have been observed from different basal activity levels with anesthesia.5052
|
In this study,39 predominantly pyramidal neurons were measured in each rat. Since >90% of all microelectrode penetrations yielded at least 2 discrete and recognizable neurons, multiple microelectrode measurements provided a reasonable estimate of the activity for the entire neuronal ensemble. The histograms of
for all stimulated conditions approached similar distributions (Figure 5), suggesting that the redeployment of the spiking frequency of the ensemble was nearly identical during forepaw stimulation with
-chloralose anesthesia. Although comparable behavior of neuronal ensembles in the cortex has been reported previously, 53,54 the quantitative redeployment of the same ensemble for different sensory workloads (ie, stimuli) provides novel insights for understanding the relationship between neuronal activity and energetics.35,40,46
|
Relating the fMRI signal to neuronal activity requires associating the fMRI signal with localized energetics and connecting energetics to neuronal processes (eg, rates of neurotransmitter release and action potential propagation). Our fMRI calibration studies in rat brain36,37 developed the first relationship, in which we related
S/S to transmission and energetics of glutamatergic neurons. Similarly, previous 13C-MRS studies of anesthetized rat brain25,55 explored the second relationship, in which a stoichiometry was found between energy metabolism (CMRO2) and neurotransmitter cycling (Vcyc) of glutamatergic neurons. In this study,39 we explored the second relationship further by examining the dependence of spiking frequency of an ensemble (
) on the localized energy metabolism (CMRO2) in the anesthetized rat brain.39,40 The combined results suggest that
|
|
which means that both electric (
) and chemical (Vcyc) activities of glutamatergic neurotransmission are proportional to the oxidative energy consumed (CMRO2). Thus, neurotransmission (ie, work done) is directly coupled to neuroenergetics (ie, energy consumed). Because the term work is defined here as the sum of the energy-consuming events associated with neuronal activity, energy connects electric and chemical aspects of neuronal work.35,40,46
| Summary |
|---|
|
|
|---|
Do brain cells utilize energy by an amount equal to the degree of work done? If so, then energy can be defined as the capability of doing work, a fundamental biophysical principle.38 We measured both CMRO2 and
were under high and low basal activity levels to determine whether the fractional increases on stimulation were equal or different.39,40 We found that
CMRO2/CMRO2

/
from both baseline activity levels on stimulation.46 Previous correlations between changes in the fMRI and electric signals of neuronal activity have provided phenomenological connections at best.3034 In contrast, the present studies demonstrate that the appropriate way of using fMRI for neuroimaging would be by way of mapping changes in energy (
CMRO2/CMRO2) with the use of calibrated fMRI36,37 because that parameter represents a biophysical representation of neuronal work (
/
and
Vcyc/Vcyc).24,46 Since the increment in energy expended is commensurate with the required work, it is suggested that neurons operate in an efficient manner in which most of the energy expended is used for the type of work that they were designed to perform (ie, receiving and distributing signals).
| Acknowledgments |
|---|
Received June 2, 2004; accepted August 5, 2004.
| References |
|---|
|
|
|---|
2. Gray CM. Synchronous oscillations in neuronal systems: mechanisms and functions. J Comput Neurosci. 1995; 1: 1138.
3. Jamieson DG, Greenberg JH. Positron emission tomography of the brain. Comput Med Imaging Graph. 1989; 13: 6179.[CrossRef][Medline] [Order article via Infotrieve]
4. Ogawa S, Lee TM, Nayak AS, Glynn P. Oxygenation-sensitive contrast in magnetic resonance image on rodent brain at high magnetic fields. Magn Reson Med. 1990; 14: 6878.[Medline] [Order article via Infotrieve]
5. Siesjo BK. Brain Energy Metabolism. New York, NY: Wiley; 1978.
6. Shulman RG, Hyder F, Rothman DL. Lactate efflux and the neuroenergetic basis of brain function. NMR Biomed. 2001; 14: 389396.[CrossRef][Medline] [Order article via Infotrieve]
7. Shulman RG, Rothman DL, Behar KL, Hyder F. Energetic basis of brain activity: implications for neuroimaging. Trends Neurosci. 2004; 27: 489495.[CrossRef][Medline] [Order article via Infotrieve]
8. Sokoloff L. Relationship between functional activity and energy metabolism in the nervous system: whether, where and why? In: Lassen NA, Ingvar DH, Raichle ME, Friberg L, eds. Brain Work and Mental Activity. Copenhagen, Denmark: Munksgaard; 1991: 5264.
9. Roy CS, Sherrington CS. On the regulation of the blood supply of the rat brain. J Physiol (Lond). 1890; 11: 85108.
10. Hill AV. The combinations of haemoglobin with oxygen and carbon monoxide. Biochem J. 1913; 7: 471480.
11. Penfield W. The evidence for a cerebral vascular mechanism in epilepsy. Ann Intern Med. 1933; 7: 303310.
12. Raichle ME, Grubb RL, Gado MH, Eichling JO, Ter-Pogossian MM. Correlation between regional cerebral blood flow and oxidative metabolism. Arch Neurol. 1976; 33: 523526.
13. Katayama Y, Tsubokawa T, Hirayama T, Kido G, Tsukiyama T, Iio M. Response of regional cerebral blood flow and oxygen metabolism to thalamic stimulation in humans as revealed by positron emission tomography. J Cereb Blood Flow Metab. 1986; 6: 637641.[Medline] [Order article via Infotrieve]
14. Fox PT, Raichle ME. Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc Natl Acad Sci U S A. 1986; 83: 11401144.
15. Roland PE, Eriksson L, Stone-Elander S, Widen L. Does mental activity change the oxidative metabolism of the brain? J Neurosci. 1987; 7: 23732389.[Abstract]
16. Fox PT, Raichle ME, Mintun MA, Dence C. Nonoxidative glucose consumption during focal physiologic neural activity. Science. 1988; 241: 462464.
17. Ginsberg MD, Chang JY, Kelley RE, Yoshii F, Barker WW, Ingenito G, Boothe TE. Increases in both cerebral glucose utilization and blood flow during execution of a somatosensory task. Ann Neurol. 1988; 23: 152160.[CrossRef][Medline] [Order article via Infotrieve]
18. Seitz RJ, Roland PE. Vibratory stimulation increases and decreases the regional cerebral blood flow and oxidative metabolism: a positron emission tomography (PET) study. Acta Neurol Scand. 1992; 86: 6067.[Medline] [Order article via Infotrieve]
19. Kuwabara H, Ohta S, Brust P, Meyer E, Gjedde A. Density of perfused capillaries in living human brain during functional activation. Prog Brain Res. 1992; 91: 209215.[Medline] [Order article via Infotrieve]
20. Ribeiro L, Kuwabara H, Meyer E, Fujita H, Marrett S, Evans A, Gjedde A. Cerebral blood flow and metabolism during non-specific bilateral visual stimulation in normal subjects. In: Uemura K, Lassen NA, Jones T, Kanno I, eds. Quantification of Brain Function: Tracer Kinetics and Image Analysis in Brain PET. Amsterdam, The Netherlands: Elsevier; 1993: 217224.
21. Marrett S, Gjedde A. Changes of blood flow and oxygen consumption in visual cortex of living humans. Adv Exp Med Biol. 1997; 413: 205208.[Medline] [Order article via Infotrieve]
22. Fujita H, Kuwabara H, Reutens DC, Gjedde A. Oxygen consumption of cerebral cortex fails to increase during continued vibrotactile stimulation. J Cereb Blood Flow Metab. 1999; 19: 266271.[CrossRef][Medline] [Order article via Infotrieve]
23. Vafaee MS, Gjedde A. Model of blood-brain transfer of oxygen explains nonlinear flow-metabolism coupling during stimulation of visual cortex. J Cereb Blood Flow Metab. 2000; 20: 747754.[Medline] [Order article via Infotrieve]
24. Hyder F. Deriving changes in CMRO2 from calibrated fMRI. In: Shulman RG, Rothman DL, eds. Brain Energetics and Neuronal Activity: Applications to fMRI and Medicine. London, UK: Wiley; 2004: 147171.
25. Rothman DL, Hyder F, Sibson NR, Behar KL, Mason GF, Shen J, Petroff OAC, Shulman RG. In vivo magnetic resonance spectroscopy studies of the glutamate and GABA neurotransmitter cycles and functional neuroenergetics. In: Davis KL, Charney D, Coyle JT, Nemeroff C, eds. Neuropsychopharmacology: The Fifth Generation of Progress. Philadelphia, Pa: Lippincott Williams & Wilkins; 2004: 315342.
26. Hyder F, Shulman RG, Rothman DL. A model for the regulation of cerebral oxygen delivery. J Appl Physiol. 1998; 85: 554564.
27. Hyder F, Kennan RP, Kida I, Mason GF, Behar KL, Rothman DL. Dependence of oxygen delivery on blood flow in rat brain: a 7 Tesla nuclear magnetic resonance study. J Cereb Blood Flow Metab. 2000; 20: 485498.[CrossRef][Medline] [Order article via Infotrieve]
28. Gjedde A. The relation between brain function and cerebral blood flow and metabolism. In: Batjer HH, ed. Cerebrovascular Disease. Philadelphia, Pa: Lippincott-Raven; 1997: 2340.
29. Buxton RB. Brain activation. In: Introduction to Functional Magnetic Resonance Imaging: Principles and Techniques. Cambridge, UK: Cambridge University Press; 2002: 4161.
30. Yang X, Hyder F, Shulman RG. Functional MRI BOLD signal coincides with electrical activity in rat whisker barrel. Magn Reson Med. 1997; 38: 874877.[Medline] [Order article via Infotrieve]
31. Brinker G, Bock C, Busch E, Krep H, Hossmann KA, Hoehn-Berlage M. Simultaneous recording of evoked potentials and T2*-weighted MR images during somatosensory stimulation of rat. Magn Reson Med. 1999; 41: 469473.[CrossRef][Medline] [Order article via Infotrieve]
32. Ogawa S, Lee TM, Stepnoski R, Chen W, Zhu XH, Ugurbil K. An approach to probe some neural systems interaction by functional MRI at neural time scale down to milliseconds. Proc Natl Acad Sci U S A. 2000; 97: 1102611031.
33. Rees G, Friston K, Koch C. A direct quantitative relationship between the functional properties of human and macaque V5. Nat Neurosci. 2000; 3: 716723.[CrossRef][Medline] [Order article via Infotrieve]
34. Logothetis NK, Pauls J, Augath M, Trinath T, Oeltermann A. Neurophysiological investigation of the basis of the fMRI signal. Nature. 2001; 412: 150157.[CrossRef][Medline] [Order article via Infotrieve]
35. Shulman RG, Hyder F, Rothman DL. Biophysical basis of brain activity: implications for neuroimaging. Q Rev Biophys. 2002; 35: 287325.[CrossRef][Medline] [Order article via Infotrieve]
36. Kida I, Kennan RP, Rothman DL, Behar KL, Hyder F. High-resolution CMRO2 mapping in rat cortex: a multi-parametric approach to calibration of BOLD image contrast at 7 Tesla. J Cereb Blood Flow Metab. 2000; 20: 847860.[CrossRef][Medline] [Order article via Infotrieve]
37. Hyder F, Kida I, Behar KL, Kennan RP, Maciejewski PK, Rothman DL. Quantitative functional imaging of the brain: towards mapping neuronal activity by BOLD fMRI. NMR Biomed. 2001; 14: 413431.[CrossRef][Medline] [Order article via Infotrieve]
38. Garby L, Larsen PS. Bioenergetics: Its Thermodynamic Foundations. Cambridge, UK: Cambridge University Press; 1995: 17.
39. Smith AJ, Blumenfeld H, Behar KL, Rothman DL, Shulman RG, Hyder F. Cerebral energetics and spiking frequency: the neurophysiological basis of fMRI. Proc Natl Acad Sci U S A. 2002; 99: 1076510770.
40. Hyder F, Rothman DL, Shulman RG. Total neuroenergetics support localized brain activity: implications for the interpretation of fMRI. Proc Natl Acad Sci U S A. 2002; 99: 1077110776.
41. Hyder F, Behar KL, Martin MA, Blamire AM, Shulman RG. Dynamic magnetic resonance imaging of the rat brain during forepaw stimulation. J Cereb Blood Flow Metab. 1994; 14: 649655.[Medline] [Order article via Infotrieve]
42. Yang X, Hyder F, Shulman RG. Single-whisker activation observed in rat cortex by functional magnetic resonance imaging. Proc Natl Acad Sci U S A. 1996; 93: 475478.
43. Xu F, Kida I, Hyder F, Shulman RG. Assessment and discrimination of odor stimuli in rat olfactory bulb by dynamic fMRI. Proc Natl Acad Sci U S A. 2000; 97: 1060110606.
44. Nersesyan H, Hyder F, Rothman DL, Blumenfeld H. Dynamic fMRI and EEG recordings during spike-wave seizures and generalized tonic-clonic seizures in WAG/Rij rats. J Cereb Blood Flow Metab. 2004; 24: 589599.[Medline] [Order article via Infotrieve]
45. Hyder F, Renken R, Kennan RP, Rothman DL. Quantitative multi-modal functional MRI with blood oxygenation level dependent exponential decays adjusted for flow attenuated inversion recoveries (BOLDED AFFAIR). Magn Reson Imag. 2000; 18: 227235.[CrossRef][Medline] [Order article via Infotrieve]
46. Hyder F, Blumenfeld H. Relationship between CMRO2 and neuronal activity. In: Shulman RG, Rothman DL, eds. Brain Energetics and Neuronal Activity: Applications to fMRI and Medicine. London, UK: Wiley; 2004: 172194.
47. Savaki HE, Desban M, Glowinski J, Besson MJ. Local cerebral glucose consumption in the rat, I: effects of halothane anesthesia. J Comp Neurol. 1981; 213: 3645.[CrossRef]
48. Dudley RE, Nelson SR, Samson F. Influence of chloralose on brain regional glucose utilization. Brain Res. 1982; 233: 173180.[CrossRef][Medline] [Order article via Infotrieve]
49. Hodes JE, Soncrant TT, Larson DM, Carlson SG, Rapoport SI. Selective changes in local cerebral glucose utilization induced by phenobarbital in the rat. Anesthesiology. 1985; 63: 633639.[Medline] [Order article via Infotrieve]
50. Harding GW, Stogsdill RM, Towe AL. Relative effects of pentobarbital and chloralose on the responsiveness of neurons in sensorimotor cerebral cortex of the domestic cat. Neuroscience. 1979; 4: 369378.[CrossRef][Medline] [Order article via Infotrieve]
51. Bonvento G, Charbonne R, Correze JL, Borredon J, Seylaz J, Lacombe P. Is alpha-chloralose plus halothane induction a suitable anesthetic regimen for cerebrovascular research? Brain Res. 1994; 665: 213221.[CrossRef][Medline] [Order article via Infotrieve]
52. Shulman RG, Rothman DL, Hyder F. Stimulated changes in localized cerebral energy consumption under anesthesia. Proc Natl Acad Sci U S A. 1999; 96: 32453250.
53. McCasland JS, Woolsey TA. High-resolution 2-deoxyglucose mapping of functional cortical columns in mouse barrel cortex. J Comp Neurol. 1988; 278: 555569.[CrossRef][Medline] [Order article via Infotrieve]
54. Scannell JW, Young MP. Neuronal population activity and functional imaging. Proc R Soc Lond B Biol Sci. 1999; 266: 875881.[Medline] [Order article via Infotrieve]
55. Rothman DL, Sibson NR, Hyder F, Shen J, Behar KL, Shulman RG. In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics. Phil Trans R Soc Lond B. 1999; 354: 11651177.
56. Desimone R. Neural mechanisms for visual memory and their role in attention. Proc Natl Acad Sci U S A. 1996; 93: 1349413499.
57. Goldman-Rakic PS. Regional and cellular fractionation of working memory. Proc Natl Acad Sci U S A. 1996; 93: 1347313480.
58. Tanaka K. Inferotemporal cortex and object vision. Annu Rev Neurosci. 1996; 19: 109139.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
U. Schridde, M. Khubchandani, J. E. Motelow, B. G. Sanganahalli, F. Hyder, and H. Blumenfeld Negative BOLD with Large Increases in Neuronal Activity Cereb Cortex, August 1, 2008; 18(8): 1814 - 1827. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |